rumor
    rumor
    • Screeners
    • Heatmaps
    • Charts
    • News
    • Documentation
    • Pricing
    • FAQ
    You're viewing limited data.
    Log inSign up

    Sign up

    24 hours of full access, free. No credit card.

    Log inPricing
    1 asset

    Market news

    TypeAll
    SortNewest
    Assets
    CVRX
    Type
    TypeAll
    All
    Sort
    SortNewest
    Newest

    Filter by asset

      CVRx (CVRX) Stock Fair Value Moves Lower After Analysts Cut Targets
      Nov 16Yahoo FinanceCVRX
      CVRx (CVRX) Q3 2026 Earnings Call Transcript

      Motley Fool Press Release.

      Nov 6The Globe and MailCVRX
      CVRx stock downgraded by Canaccord on guidance cut, payer headwinds
      Nov 6Investing.comCVRX
      CVRx Inc (CVRX) Q3 2026 Earnings Call Highlights: Revenue Misses Guidance as Reimbursement ...
      Nov 6Yahoo FinanceCVRX
      William Blair downgrades CVRx stock rating on reimbursement headwinds
      Nov 6Investing.comCVRX
      CVRx (CVRX) Reports Q3 Loss, Lags Revenue Estimates
      Nov 6Yahoo FinanceCVRX
      Here's What Key Metrics Tell Us About CVRx (CVRX) Q3 Earnings
      Nov 5Yahoo FinanceCVRX
      CVRx: Q3 Earnings Snapshot
      Nov 5Yahoo FinanceCVRX
      CVRx earnings missed by $0.02, revenue fell short of estimates
      Nov 5Investing.comCVRX
      CVRx Reports Third Quarter 2026 Financial and Operating Results
      Nov 5Yahoo FinanceCVRX
      Earnings To Watch: CVRx Inc (CVRX) Q3 2026 -- GF Value Sees 667% Upside
      Nov 4Yahoo FinanceCVRX
      CVRx to Participate in Upcoming Investor Conferences
      Nov 2Yahoo FinanceCVRX
      CVRx Reports Q2 2026 Results: Full Earnings Call Transcript - CVRx (NASDAQ:CVRX)

      On Thursday, CVRx (NASDAQ:CVRX) discussed second-quarter financial results during its earnings call. The full transcript is provided below. This content is powered by Benzinga APIs. For comprehensive financial data and

      Oct 12BenzingaCVRX
      CVRx Announces Late-Breaking Data and New Clinical Evidence on Barostim at the HFSA Annual Scientific Meeting 2026
      Sep 29Yahoo FinanceCVRX
      CVRx names John Landry as CFO
      Sep 23Yahoo FinanceCVRX
      Lake Street Remains a Hold on CVRx (CVRX)

      Detailed price information for Cvrx Inc (CVRX-Q) from The Globe and Mail including charting and trades.

      Sep 23The Globe and MailCVRX
      Analysts Conflicted on These Healthcare Names: Novo Nordisk (NVO) and CVRx (CVRX)

      Detailed price information for Novo Nordisk A/S ADR (NVO-N) from The Globe and Mail including charting and trades.

      Sep 23The Globe and MailCVRX
      Canaccord reiterates CVRx stock Buy rating after CFO appointment
      Sep 22Investing.comCVRX
      CVRx Names New Chief Financial Officer
      Sep 21Yahoo FinanceCVRX
      CVRx Appoints John Landry as Chief Financial Officer

      Landry Brings Two Decades of Medtech and Public Company Finance ExperienceMINNEAPOLIS, Sept. 21, 2026 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) ("CVRx"), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions for patients with cardiovascular diseases, today announced that John Landry has been appointed Chief Financial Officer, succeeding Jared Oasheim, whose resignation was previously announced. Mr. Landry will

      Sep 21Yahoo FinanceCVRX
      CVRx Secures Devoted Health Coverage for Barostim Therapy

      CVRX secures Devoted Health Medicare Advantage coverage for Barostim, expanding reimbursement access to about 466,000 members across 29 states.

      Aug 28Yahoo FinanceCVRX
      CVRx responds to shareholder letter on company valuation
      Aug 25Investing.comCVRX
      CVRx Responds to Letter from Pointillist Family Office
      Aug 25Yahoo FinanceCVRX
      Investor holding 5.5% of CVRx urges board to pursue sale By Investing.com
      Aug 24Investing.comCVRX
      CVRx Announces Devoted Health Medicare Advantage Coverage Policy for Barostim Therapy

      MINNEAPOLIS, Aug. 24, 2026 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions for patients with cardiovascular diseases, announced today that Devoted Health has issued a Medicare Advantage coverage policy for Barostim therapy, effective July 17, 2026. Devoted Health, a national health insurance company with the eighth largest Medicare Advantage enrollment i

      Aug 24Yahoo FinanceCVRX
      Jorey Chernett, Owner of More than 5.5% of Outstanding Shares of CVRx, Calls on Board to Begin Immediate Process to Pursue Sale of the Company to a Strategic Acquirer

      Jorey Chernett, Founder of Pointillist Family Office and beneficial owner of more than 5.5% of the outstanding shares of CVRx, Inc. ("CVRx" or the "Company") (NASDAQ: CVRx), today delivered a letter to the CVRx Board of Directors (the "Board"), urging it to launch an immediate and formal process to sell the Company to a strategic acquirer.

      Aug 24Yahoo FinanceCVRX

      This is the newest page. Registered accounts read further back.